Literature DB >> 18528932

Etiopathogenesis of primary sclerosing cholangitis.

Roger Chapman1, Sue Cullen.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease. Associations with inflammatory bowel disease (IBD) especially ulcerative colitis (UC), and with particular autoimmune diseases, as well as the genetic associations further suggest PSC may be an immune-mediated disease. The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease. Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease. PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528932      PMCID: PMC2716589          DOI: 10.3748/wjg.14.3350

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  85 in total

Review 1.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

2.  No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Authors:  Kristine Wiencke; Kirsten Muri Boberg; Peter Donaldson; Hanne Harbo; Vincent Ling; Erik Schrumpf; Anne Spurkland
Journal:  Scand J Gastroenterol       Date:  2006-05       Impact factor: 2.423

Review 3.  Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.

Authors:  Cynthia Levy; Keith D Lindor
Journal:  Semin Liver Dis       Date:  2006-02       Impact factor: 6.115

4.  Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; G K Sachdev; A Heryet; P M Kelly; K A Fleming; D P Jewell
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

5.  The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.

Authors:  E Melum; T H Karlsen; U Broomé; E Thorsby; E Schrumpf; K M Boberg; B A Lie
Journal:  Tissue Antigens       Date:  2006-07

6.  HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

Authors:  W Z Mehal; Y M Lo; B P Wordsworth; J M Neuberger; S C Hubscher; K A Fleming; R W Chapman
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

7.  Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Authors:  K Hata; D H Van Thiel; R B Herberman; T L Whiteside
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

8.  MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).

Authors:  A J Grant; P F Lalor; S G Hübscher; M Briskin; D H Adams
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

9.  Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.

Authors:  Takeshi Uehara; Hideaki Hamano; Shigeyuki Kawa; Kenji Sano; Takayuki Honda; Hiroyoshi Ota
Journal:  Pathol Int       Date:  2005-07       Impact factor: 2.534

10.  Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

Authors:  Xuesong Yang; Susan N Cullen; Jin H Li; Roger W Chapman; Derek P Jewell
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

View more
  22 in total

1.  Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

Authors:  A M Arenas-Gamboa; J J Bearss; G B Hubbard; B F Porter; M A Owston; E J Dick
Journal:  Vet Pathol       Date:  2011-09-20       Impact factor: 2.221

2.  Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Authors:  Anna Baghdasaryan; Thierry Claudel; Astrid Kosters; Judith Gumhold; Dagmar Silbert; Andrea Thüringer; Katharina Leski; Peter Fickert; Saul J Karpen; Michael Trauner
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

Review 3.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

4.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

5.  Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.

Authors:  Brian D Juran; Elizabeth J Atkinson; Erik M Schlicht; Joseph J Larson; David Ellinghaus; Andre Franke; Konstantinos N Lazaridis
Journal:  Liver Int       Date:  2010-12-07       Impact factor: 5.828

6.  Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.

Authors:  Marcel Janse; Laetitia E Lamberts; Lude Franke; Soumya Raychaudhuri; Eva Ellinghaus; Kirsten Muri Boberg; Espen Melum; Trine Folseraas; Erik Schrumpf; Annika Bergquist; Einar Björnsson; Jingyuan Fu; Harm Jan Westra; Harry J M Groen; Rudolf S N Fehrmann; Joanna Smolonska; Leonard H van den Berg; Roel A Ophoff; Robert J Porte; Tobias J Weismüller; Jochen Wedemeyer; Christoph Schramm; Martina Sterneck; Rainer Günther; Felix Braun; Severine Vermeire; Liesbet Henckaerts; Cisca Wijmenga; Cyriel Y Ponsioen; Stefan Schreiber; Tom H Karlsen; Andre Franke; Rinse K Weersma
Journal:  Hepatology       Date:  2011-05-02       Impact factor: 17.425

Review 7.  TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?

Authors:  Verena Keitel; Maria Reich; Dieter Häussinger
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 8.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

Review 9.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.